Man Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-965,093
Closed -$98M 2450
2025
Q4
$98M Buy
965,093
+936,071
+3,225% +$75.2M 0.17% 141
2025
Q3
$1.59M Sell
29,022
-454,187
-94% -$22.7M ﹤0.01% 1513
2025
Q2
$25.7M Buy
483,209
+355,165
+277% +$18M 0.05% 415
2025
Q1
$5.54M Buy
128,044
+68,042
+113% +$3.45M 0.01% 980
2024
Q4
$3.37M Buy
+60,002
New +$3.73M 0.01% 1155
2024
Q3
Sell
-13,539
Closed -$572K 2035
2024
Q2
$572K Sell
13,539
-79,410
-85% -$4.37M ﹤0.01% 1654
2024
Q1
$6.42M Sell
92,949
-226,130
-71% -$14.3M 0.02% 888
2023
Q4
$23.6M Buy
+319,079
New +$20.9M 0.07% 346
2023
Q3
Sell
-320,798
Closed -$27.2M 274
2023
Q2
$30.1M Buy
+320,798
New +$25M 0.09% 265
2023
Q1
Sell
-296,227
Closed -$19M 751
2022
Q4
$14.7M Buy
296,227
+139,086
+89% +$5.68M 0.05% 427
2022
Q3
$5.11M Buy
+157,141
New +$6.48M 0.02% 730
2022
Q2
Hold
0
1618
2022
Q1
Sell
-11,238
Closed -$875K 2219
2021
Q4
$875K Sell
11,238
-39,419
-78% -$3.48M ﹤0.01% 1364
2021
Q3
$4.83M Buy
50,657
+21,992
+77% +$2.32M 0.02% 851
2021
Q2
$3.56M Buy
28,665
+26,807
+1,443% +$3.2M 0.01% 1024
2021
Q1
$245K Sell
1,858
-17,801
-91% -$2.44M ﹤0.01% 1688
2020
Q4
$2.6M Sell
19,659
-4,874
-20% -$589K 0.01% 1103
2020
Q3
$2.5M Sell
24,533
-23,895
-49% -$2.06M 0.01% 1118
2020
Q2
$4.21M Buy
48,428
+43,875
+964% +$3.51M 0.02% 753
2020
Q1
$264K Buy
4,553
+1,881
+70% +$153K ﹤0.01% 1412
2019
Q4
$247K Buy
+2,672
New +$235K ﹤0.01% 1715
2019
Q2
Sell
-21,257
Closed -$1.84M 1920
2019
Q1
$1.84M Buy
21,257
+13,186
+163% +$1.12M 0.01% 1368
2018
Q4
$509K Sell
8,071
-1,153
-13% -$79.1K ﹤0.01% 1623
2018
Q3
$728K Buy
+9,224
New +$601K ﹤0.01% 1761
2018
Q2
Sell
-10,933
Closed -$441K 2145
2018
Q1
$441K Buy
+10,933
New +$533K ﹤0.01% 1749

Other funds holding EXAS

Man Group's EXAS Position: Q1 2026 in Review

Man Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 965,093 shares — an estimated $98M sold.

Man Group first reported a position in EXAS in Q1 2018 and held it in 24 quarters. The position peaked at $98M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Man Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 965,093 Exact Sciences shares in Q1 2026, an estimated $98M.
  • Man Group first reported a position in Exact Sciences in Q1 2018 and held it in 24 quarters.
  • Man Group's Exact Sciences position peaked at $98M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.